Conference Coverage

Sex differences seen in inflammatory arthritis health care use


 

FROM THE LANCET SUMMIT ON SEX AND GENDER IN RHEUMATOLOGY

Women seek out care, do repeat visits

Several reasons may explain why utilization was higher in females. Women with IA have a higher overall risk of musculoskeletal conditions such as osteoarthritis, which could have driven the health care encounters. Numerous studies have also reported that female patients have a lower threshold for pain as well as a greater tendency to seek out health care.

Additionally, female patients often present with pain and fatigue, which are often misdiagnosed as fibromyalgia or depression. Therefore, they often require repeated health care encounters to arrive at an IA diagnosis, Ms. Tarannum said.

An early prodromal phase in females could have triggered a health care encounter as well.

Men, by comparison, are more likely to have acute-onset or severe disease. Objective signs and radiologic features can facilitate diagnosis in men, she said. Male patients also show more reluctance in seeking care, have a higher threshold for pain, and are less likely to have a usual source of care such as a family physician.

Higher confidence in hospital-based emergency services also could have resulted in more ED visits and lower health care use in men. Better response to treatments could also have resulted in fewer episodes of rheumatology care after diagnosis.

The results aren’t surprising, said Scott Zashin, MD, a rheumatologist in Dallas who wasn’t a part of the study.

“At least in terms of musculoskeletal disorders, my clinical experience suggests that women are more compliant with their follow-up than male patients. Especially with gout, a common type of arthritis in men, male patients may wait until their symptoms are severe before seeking medical attention,” Dr. Zashin said.

The Enid Walker Graduate Student Award for Research in Women’s Health provided funding for this study.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Better COVID-19 outcomes confirmed in TNF inhibitor users
Journal of Clinical Outcomes Management
Statins’ effects on CVD outweigh risk for diabetes in RA
Journal of Clinical Outcomes Management
mRNA COVID vaccine response found mostly robust in RA, SLE patients
Journal of Clinical Outcomes Management
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis population
Journal of Clinical Outcomes Management
Abortion debate may affect Rx decisions for pregnant women
Journal of Clinical Outcomes Management
No more ‘escape hatch’: Post Roe, new worries about meds linked to birth defects
Journal of Clinical Outcomes Management
Feds warn pharmacists: Don’t refuse to provide abortion pills
Journal of Clinical Outcomes Management
Methotrexate’s impact on COVID-19 vaccination: New insights made
Journal of Clinical Outcomes Management
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
Journal of Clinical Outcomes Management
Severe COVID-19–related outcomes found worse in men with RA
Journal of Clinical Outcomes Management